INNOGEN-B (02591) Plans to Implement H-Share Full Circulation Scheme

Stock News03-17

INNOGEN-B (02591) announced that on March 17, 2026, the company submitted an application to the China Securities Regulatory Commission for the proposed conversion of all its domestic unlisted shares into H-shares. Upon obtaining all relevant approvals and/or completing required filings—including the filing notice from the CSRC and approval from the Hong Kong Stock Exchange—and complying with all applicable laws, rules, and regulations, these domestic non-listed shares will be converted into H-shares. The company will then apply for approval to list and trade these H-shares on the Main Board of the Hong Kong Stock Exchange. According to the company's articles of association, no further shareholder meeting approval is required for the conversion and listing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment